The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

The clarification from the German biotech company comes on the heels of a Bloomberg report that Pfizer is considering selling ...

Pfizer sell 508M stake in BioNTech through an overnight block trade, marking its exit from the COVID-19 vaccine partner's equity.

Shares of COVID-19 vaccine makers Pfizer Inc (NYSE:PFE), BioNTech SE ADR (NASDAQ:BNTX) and Moderna Inc (NASDAQ:MRNA) are trading lower Friday following a Washington Post report that Trump ...

VLA15-221 Phase 2 study: strong immune response shown one month after a second booster dose (month 31) in pediatric and adult populations Significant anamnestic antibody response observed across all ...

The US drugmaker is offering about 4.55 million American depositary receipts via an overnight block trade marketed between ...

WASHINGTON -- Pfizer announced Friday that it submitted a request to the U.S. Food and Drug Administration to allow emergency use of its COVID-19 vaccine to children as young as 12. This is the next ...

Pfizer CEO Albert Bourla said people will "likely" need a booster dose of a COVID-19 vaccine within 12 months of getting fully vaccinated. His comments were made public Thursday but were taped April 1 ...

The Food and Drug Administration could fully approve the two-dose Pfizer COVID-19 vaccine as early as Monday, according to multiple reports. Pfizer, Moderna, and Johnson & Johnson are currently ...

Drug maker Pfizer says it's planning to start testing its COVID-19 vaccine on children as young as 12. This will be the first coronavirus vaccine trial to include children in the United States. The ...